• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Hemab Therapeutics Holdings, Inc. - Common Stock (NQ:COAG)

    54.94 +0.99 (+1.84%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 14, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 101,168
    Open 53.76
    Bid (Size) 39.00 (100)
    Ask (Size) 85.61 (100)
    Prev. Close 53.95
    Today's Range 50.59 - 55.42
    52wk Range 23.00 - 55.42
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Hemab Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
    From Hemab Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress
    From Hemab Therapeutics, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +61.6%
    +61.6%
    1 Month
    +26.8%
    +26.8%
    3 Month
    +95.7%
    +95.7%
    6 Month
    +61.6%
    +61.6%
    1 Year
    +61.6%
    +61.6%

    More News

    Read More
    News headline image
    Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress
    From Hemab Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the ISTH 2026 Congress
    From Hemab Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Hemab Therapeutics Details Post-IPO Pipeline Push, Sutacimig Phase III Plans ↗
    Via MarketBeat
    News headline image
    Hemab Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
    From Hemab Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Hemab Therapeutics Reports First Quarter 2026 Financial Results
    From Hemab Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
    From Hemab Therapeutics, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Hemab Therapeutics Holdings, Inc. - Common Stock publicly traded?
    Yes, Hemab Therapeutics Holdings, Inc. - Common Stock is publicly traded.
    What exchange does Hemab Therapeutics Holdings, Inc. - Common Stock trade on?
    Hemab Therapeutics Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Hemab Therapeutics Holdings, Inc. - Common Stock?
    The ticker symbol for Hemab Therapeutics Holdings, Inc. - Common Stock is COAG on the Nasdaq Stock Market
    What is the current price of Hemab Therapeutics Holdings, Inc. - Common Stock?
    The current price of Hemab Therapeutics Holdings, Inc. - Common Stock is 54.94
    When was Hemab Therapeutics Holdings, Inc. - Common Stock last traded?
    The last trade of Hemab Therapeutics Holdings, Inc. - Common Stock was at 08/14/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.